Evaluate GH stock safety — financial health, volatility, institutional backing, and risk factors.

What are the risks of investing in GH? | Glauxie AI

Q: What are the risks of investing in GH?

Guardant Health, Inc. (GH) operates in the Medical - Diagnostics & Research industry (Healthcare sector). The company is led by CEO Helmy Eltoukhy. Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT,... Employees: 24,000.

Q: How much debt does GH have?

Review GH total debt, debt-to-equity ratio, interest coverage, and leverage trends.

Q: Is GH a good long-term investment?

Evaluate GH as a long-term investment using fundamental scores, growth metrics, and risk assessment.

What are the risks of investing in GH?

🦉

Guardant Health, Inc. (GH)

Company Overview

Sector / IndustryHealthcare / Medical - Diagnostics & Research

CEOHelmy Eltoukhy

Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM,...

Key Executives

Name	Title
AmirAli Talasaz	Co-CEO & Director
Andy Ament	Senior Vice President of Operations
Craig Eagle	Chief Medical Officer
Darya Chudova	Chief Technology Officer
Gulshan Shaver	Senior Vice President of Legal Affairs & Chief Compliance Officer
Helmy Eltoukhy	Co-Founder, Co-CEO & Chairman

Financial Health

Risk Assessment

Weather Score0/100

RegimeN/A

GH Profile Financials

Is GH stock safe? How much debt does GH have? Is GH a good long-term investment?